BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33779555)

  • 1. Not All Bethesda 1 Thyroid Nodules Were Created Equal: Different B1 Subgroups.
    Raveh Gildin N; Cohen H; Ronen O
    Endocr Pract; 2021 Mar; 27(3):223-227. PubMed ID: 33779555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the Bethesda system for reporting thyroid cytopathology.
    Na DG; Kim JH; Sung JY; Baek JH; Jung KC; Lee H; Yoo H
    Thyroid; 2012 May; 22(5):468-75. PubMed ID: 22304417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeat Diagnoses of Bethesda Category III Thyroid Nodules: What To Do Next?
    Yoo MR; Gweon HM; Park AY; Cho KE; Kim JA; Youk JH; Son EJ
    PLoS One; 2015; 10(6):e0130138. PubMed ID: 26115096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of malignancy rate in thyroid nodules according to the Bethesda system of fine-needle aspiration. Report from a tertiary center in the Southwestern region of Saudi Arabia.
    Al-Shraim MM; Kaood OM; Hussein MR; Al-Ahmary AM; Al Shehri GY; Jastania RA; Mahfouz AA; Abu-Eshy SA
    Saudi Med J; 2012 Feb; 33(2):167-71. PubMed ID: 22327757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal timing for a repeat fine-needle aspiration biopsy of thyroid nodule following an initial nondiagnostic fine-needle aspiration.
    Deniwar A; Hammad AY; Ali DB; Alsaleh N; Lahlouh M; Sholl AB; Moroz K; Aslam R; Thethi T; Kandil E
    Am J Surg; 2017 Feb; 213(2):433-437. PubMed ID: 27475222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On-site fine-needle aspiration cytology of thyroid nodules. Quality assurance of the Bethesda System for Reporting Thyroid Cytopathology (2008)].
    Bak M; Péter I; Nyári T; Simon P; Újlaky M; Boér A; Kásler M
    Orv Hetil; 2015 Oct; 156(41):1661-6. PubMed ID: 26551169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytology-Ultrasonography Risk-Stratification Scoring System Based on Fine-Needle Aspiration Cytology and the Korean-Thyroid Imaging Reporting and Data System.
    Hong MJ; Na DG; Baek JH; Sung JY; Kim JH
    Thyroid; 2017 Jul; 27(7):953-959. PubMed ID: 28463597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine needle aspiration of thyroid nodules in the pediatric population: a 12-year cyto-histological correlation experience at North Shore-Long Island Jewish Health System.
    Lale SA; Morgenstern NN; Chiara S; Wasserman P
    Diagn Cytopathol; 2015 Aug; 43(8):598-604. PubMed ID: 25728981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Implementation of the Bethesda system for reporting the thyroid cytopathology: study on 5 729 cases from a cancer center].
    Guo HQ; Zhao H; Cao J; Zhao LL; Sun Y; Wang C; Zhang ZH
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Mar; 55(3):258-262. PubMed ID: 32268696
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of the bethesda system for reporting thyroid cytopathology and similar precursor thyroid cytopathology reporting schemes.
    Wong LQ; Baloch ZW
    Adv Anat Pathol; 2012 Sep; 19(5):313-9. PubMed ID: 22885380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine needle aspiration of the thyroid: correlation with final histopathology in a surgical series of 797 patients.
    Lew JI; Snyder RA; Sanchez YM; Solorzano CC
    J Am Coll Surg; 2011 Jul; 213(1):188-94; discussion 194-5. PubMed ID: 21601489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
    Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
    Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does a higher American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) score forecast an increased risk of malignancy? A correlation study of ACR TI-RADS with FNA cytology in the evaluation of thyroid nodules.
    Modi L; Sun W; Shafizadeh N; Negron R; Yee-Chang M; Zhou F; Simsir A; Sheth S; Brandler TC
    Cancer Cytopathol; 2020 Jul; 128(7):470-481. PubMed ID: 32078249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology.
    Yaprak Bayrak B; Eruyar AT
    BMC Endocr Disord; 2020 Apr; 20(1):48. PubMed ID: 32293401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Value of Negative Diagnosis in Thyroid Fine-Needle Aspiration: a Retrospective Study with Histologic Follow-Up.
    Abi-Raad R; Prasad M; Baldassari R; Schofield K; Callender GG; Chhieng D; Adeniran AJ
    Endocr Pathol; 2018 Sep; 29(3):269-275. PubMed ID: 29949024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-Up Strategies for Thyroid Nodules with Benign Cytology on Ultrasound-Guided Fine Needle Aspiration: Malignancy Rates of Management Guidelines Using Ultrasound Before and After the Era of the Bethesda System.
    Yoon JH; Lee HS; Kim EK; Moon HJ; Park VY; Kwak JY
    Thyroid; 2019 Sep; 29(9):1227-1236. PubMed ID: 31359839
    [No Abstract]   [Full Text] [Related]  

  • 17. Thyroid Ultrasound-Guided Fine-Needle Aspiration Cytology Results: Observed Increase in Indeterminate Rate over the Past Decade.
    Manning AM; Yang H; Falciglia M; Mark JR; Steward DL
    Otolaryngol Head Neck Surg; 2017 Apr; 156(4):611-615. PubMed ID: 28118554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bethesda System for Reporting Thyroid Cytopathology in Pediatric Thyroid Nodules: Experience of a Tertiary Care Referral Center.
    Heider A; Arnold S; Jing X
    Arch Pathol Lab Med; 2020 Apr; 144(4):473-477. PubMed ID: 31403334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified Bethesda system informing cytopathologic adequacy improves malignancy risk stratification in nodules considered benign or atypia(follicular lesion) of undetermined significance.
    Lee YB; Kim JY; Cho H; Hahn SY; Shin JH; Lee SE; Jun JE; Kim SW; Chung JH; Kim TH; Oh YL
    Sci Rep; 2018 Sep; 8(1):13503. PubMed ID: 30202035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining the Bethesda criteria risk stratification of thyroid nodules.
    Deniwar A; Hambleton C; Thethi T; Moroz K; Kandil E
    Pathol Res Pract; 2015 May; 211(5):345-8. PubMed ID: 25796296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.